Goldman Sachs’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,189
Closed -$18.8K 6009
2024
Q1
$18.8K Buy
31,189
+825
+3% +$506 ﹤0.01% 5396
2023
Q4
$17.8K Buy
+30,364
New +$18.3K ﹤0.01% 5449
2023
Q2
Sell
-6,555
Closed -$59.6K 6160
2023
Q1
$59.6K Buy
6,555
+576
+10% +$8.16K ﹤0.01% 5528
2022
Q4
$70.1K Sell
5,979
-4,079
-41% -$71.9K ﹤0.01% 5547
2022
Q3
$213K Sell
10,058
-30,259
-75% -$816K ﹤0.01% 5446
2022
Q2
$978K Buy
40,317
+6,864
+21% +$234K ﹤0.01% 4627
2022
Q1
$1.67M Sell
33,453
-4,999
-13% -$247K ﹤0.01% 4398
2021
Q4
$2.7M Buy
38,452
+27,272
+244% +$2.3M ﹤0.01% 3984
2021
Q3
$1.04M Buy
11,180
+4,440
+66% +$422K ﹤0.01% 4708
2021
Q2
$677K Buy
6,740
+1,213
+22% +$118K ﹤0.01% 5029
2021
Q1
$516K Buy
5,527
+911
+20% +$92.4K ﹤0.01% 5092
2020
Q4
$381K Sell
4,616
-6,321
-58% -$539K ﹤0.01% 4768
2020
Q3
$938K Buy
10,937
+8,336
+320% +$971K ﹤0.01% 4127
2020
Q2
$242K Sell
2,601
-2,766
-52% -$152K ﹤0.01% 4719
2020
Q1
$152K Buy
5,367
+2,051
+62% +$79.7K ﹤0.01% 4800
2019
Q4
$137K Buy
+3,316
New +$72.6K ﹤0.01% 4994
2019
Q3
Sell
-18,321
Closed -$643K 5431
2019
Q2
$643K Buy
+18,321
New +$993K ﹤0.01% 4273
2018
Q4
Sell
-1,396
Closed -$101K 5775
2018
Q3
$101K Sell
1,396
-3,583
-72% -$236K ﹤0.01% 5137
2018
Q2
$411K Buy
+4,979
New +$481K ﹤0.01% 4619
2017
Q2
Sell
-2,323
Closed -$383K 7027
2017
Q1
$383K Buy
+2,323
New +$314K ﹤0.01% 5252
2016
Q2
Sell
-1,215
Closed -$86K 7294
2016
Q1
$86K Buy
1,215
+447
+58% +$29.6K ﹤0.01% 6149
2015
Q4
$56K Sell
768
-5
-0.6% -$382 ﹤0.01% 6484
2015
Q3
$61K Buy
+773
New +$61.3K ﹤0.01% 6717
2015
Q1
Sell
-806
Closed -$81K 7330
2014
Q4
$81K Buy
+806
New +$63.6K ﹤0.01% 6655

Other funds holding VBIV